Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN, Wareham NJ, Kastelein JJ, Khaw KT, Boekholdt SM
Journal of lipid research. Aug 2009
(DOI : 10.1194/P900038-JLR200)
Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.
Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM
Circulation. Oct 2007
(DOI : 10.1161/CIRCULATIONAHA.107.704031)
Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM
Journal of the American College of Cardiology. Nov 2006
(DOI : 10.1016/j.jacc.2007.03.033)
El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM
Journal of the American College of Cardiology. Aug 2006
(DOI : 10.1016/j.jacc.2006.09.043)
Vaessen SF, Schaap FG, Kuivenhoven JA, Groen AK, Hutten BA, Boekholdt SM, Hattori H, Sandhu MS, Bingham SA, Luben R, Palmen JA, Wareham NJ, Humphries SE, Kastelein JJ, Talmud PJ, Khaw KT
Journal of lipid research. Jun 2006
(DOI : 10.1194/jlr.M600233-JLR200)
Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT, Boekholdt SM
Arteriosclerosis, thrombosis, and vascular biology. Dec 2005
(DOI : 10.1161/01.ATV.0000201038.47949.56)
Role of CETP inhibitors in the treatment of dyslipidemia.
van der Steeg WA, Kuivenhoven JA, Klerkx AH, Boekholdt SM, Hovingh GK, Kastelein JJ
Current opinion in lipidology. Nov 2004
(DOI : 10.1097/00041433-200412000-00002)
Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, Bingham SA, Day NE, Kastelein JJ, Khaw KT
Circulation. Sep 2004
(DOI : 10.1161/01.CIR.0000141730.65972.95)